AI developer Lunit's Insight suite for early cancer detection will be included in CancerX's first project.
The project will address the issues of increasing equity and reducing financial burden in cancer care, Lunit said.
The Insight suite includes Insight CXR for chest x-ray analysis and Insight MMG for mammogram analysis. It has shown a 20% increase in early cancer diagnoses, a 40% reduction in reading time, and a 30% reduction in recall rates, according to the firm.
Lunit is a founding member of CancerX.
